Wilmer Cutler Pickering Hale and Dorr represented Arbor Biotechnologies in the transaction. Arbor Biotechnologies announced a strategic partnership with 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT). As part of...
Arbor Biotechnologies’ Partnership with 4D Molecular Therapeutics
Arbor Biotechnologies’ $215 Million Series B Financing
Ropes & Gray advised Arbor Biotechnologies on the deal. Arbor Biotechnologies announced an oversubscribed and up-sized $215 million Series B financing. Arbor plans to use the...